Selected article for: "serum virus and virus control"

Author: Ria Lassaunière; Anders Frische; Zitta B Harboe; Alex CY Nielsen; Anders Fomsgaard; Karen A Krogfelt; Charlotte S Jørgensen
Title: Evaluation of nine commercial SARS-CoV-2 immunoassays
  • Document date: 2020_4_10
  • ID: 8cg5yj20_25
    Snippet: In the present study, three SARS-CoV-2-specific commercial ELISA assays and six POC rapid tests were evaluated using sera from hospitalized adult patients with PCR-confirmed diagnoses for SARS-CoV-2 and a collection of control serum samples taken before the emergence of the virus in China in December 2019......
    Document: In the present study, three SARS-CoV-2-specific commercial ELISA assays and six POC rapid tests were evaluated using sera from hospitalized adult patients with PCR-confirmed diagnoses for SARS-CoV-2 and a collection of control serum samples taken before the emergence of the virus in China in December 2019.

    Search related documents:
    Co phrase search for related documents
    • China virus emergence and virus emergence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • commercial ELISA assay and present study: 1, 2
    • commercial ELISA assay and rapid test: 1, 2, 3
    • control serum and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • control serum and rapid test: 1
    • PCR confirm and present study: 1, 2, 3, 4, 5, 6, 7, 8
    • PCR confirm and rapid test: 1, 2, 3, 4, 5, 6
    • PCR confirm and SARS PCR confirm diagnosis: 1, 2
    • PCR confirm diagnosis and SARS PCR confirm diagnosis: 1, 2
    • POC rapid test and rapid test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • present study and rapid test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • present study and virus emergence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • rapid test and virus emergence: 1, 2, 3, 4